Remicade is given by a healthcare professional as an intravenous (IV) infusion (an injection into your vein given over a period of time). An interaction can occur because one substance causes ...

Johnson & Johnson has come out fighting after Pfizer announced yesterday that it is ready to launch a biosimilar competitor to its blockbuster Remicade. J&J said it had a “biosimilar ...

Expert Rev Clin Immunol. 2010;6(1):9-19. In a large study with a total of 165 consecutive patients who received 479 infliximab infusions, [111] the overall incidence of infusion reactions was ...